Table 3.
Identification of HBV markers among study participants by demographic characteristics.
| Variable | HBeAg (+) § | Anti-Hbe § (+) |
Anti-HBc † (+) |
Anti-HBs † (+) |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | |
| Gender | p = 0.031 | p = 0.674 | p = 0.807 | p = 0.0001 |
| Male | 61 (17.4) | 272 (77.9) | 1732 (43.6) | 1414 (37.5) |
| Female | 33 (11.4) | 230 (79.3) | 2631 (43.9) | 2519 (43.4) |
| Age group | p = 0.557 | p = 0.0001 | p = 0.0001 | p = 0.0001 |
| 10–19 | 6 (18.2) | 7 (21.2) | 87 (4.0) | 665 (31.0) |
| 20–29 | 23 (19.7) | 87 (74.4) | 632 (34.3) | 624 (35.1) |
| 30–39 | 29 (12.9) | 187 (83.9) | 1570 (60.2) | 1124 (45.5) |
| 40–49 | 20 (12.9) | 130 (83.9) | 1092 (60.6) | 822 (48.1) |
| 50–59 | 14 (15.4) | 75 (82.4) | 787 (62.1) | 571 (48.0) |
| 60< | 2 (10.0) | 16 (80.0) | 195 (66.1) | 127 (45.7) |
| Residence | p = 0.127 | p = 0.443 | p = 0.001 | p = 0.0001 |
| Rural | 44 (12.7) | 275 (79.7) | 1585 (46.2) | 1523 (44.4) |
| Urban | 50 (17.0) | 227 (77.2) | 2778 (42.5) | 2410 (39.2) |
| Total | 94 (14.7) | 502 (78.6) | 4363 (43.8) | 3933 (41.1) |
§ HBeAg and anti-HBe markers were tested among 939 HBsAg-positive subjects. † Anti-HBc and anti-HBs markers were tested in all study participants (n = 10,040).